CHENNAI: State to spend Rs 35 lakh more for common drug

Amid opposition from several states, the Union health ministry restricted the manufacture and sale of oxytocin to just Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL), a public sector undertaking, from September 1.

WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.